Ovarian cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Fahimeh Shojaei (talk | contribs)
No edit summary
Fahimeh Shojaei (talk | contribs)
No edit summary
Line 717: Line 717:
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal]]
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal]]
[[Bladder]]
[[Bladder]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pelvic kidney]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pelvic kidney]]<ref name="WeizerSpringhart2005">{{cite journal|last1=Weizer|first1=Alon Z.|last2=Springhart|first2=W. Patrick|last3=Ekeruo|first3=Wesley O.|last4=Matlaga|first4=Brian R.|last5=Tan|first5=Yeh H.|last6=Assimos|first6=Dean G.|last7=Preminger|first7=Glenn M.|title=Ureteroscopic management of renal calculi in anomalous kidneys|journal=Urology|volume=65|issue=2|year=2005|pages=265–269|issn=00904295|doi=10.1016/j.urology.2004.09.055}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* NA
* NA

Revision as of 14:25, 12 February 2019

Ovarian cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classifications

Pathophysiology

Causes of Ovarian cancer

Differentiating Ovarian cancer from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian cancer differential diagnosis

CDC on Ovarian cancer differential diagnosis

Ovarian cancer differential diagnosis in the news

Blogs on Ovarian cancer differential diagnosis

Directions to Hospitals Treating Ovarian cancer

Risk calculators and risk factors for Ovarian cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Differentiating [Disease name] from other Diseases

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Age of onset Symptoms Physical examination
Lab Findings Imaging Immunohistopathology
pelvic/abdominal pain or pressure vaginal bleeding/discharge GI dysturbance Fever Tenderness CT scan/US MRI
Gynecologic
Ovarian Follicular cysts +/– +/–
  • In US we may see a >3 cm simple cyst with no internal echo and with posterior acoustic enhancement
  • simple cyst with no internal echo or septa
  • NA
Theca lutein cysts +/– +/–
Serous cystadenoma/carcinoma
  • >55 y/o
+/– +/–
  • In US we may see simple or multiloculated cyst
  • In serous cystadenocarcinoma we may see papillary projection inside the cyst
  • In serous cystadenocarcinoma we may see ascites
  • In Serous cystadenoma we may see a simple cyst with beak sign, hypointense on T1 and hyperintense on T2
  • In serous cystadenocarcinoma we may see some Solid malignant components inside the cyst with intermediate signal on T1 and T2
Mucinous cystadenoma/carcinoma
  • >55 y/o
+/– +/–
  • Stained glass appearance due to variable signal intensity on T1 and T2
  • The more mucin we have, there is more intensity on T1
  • and less intensity on T2
Endometrioma + + +/– +
  • hyperintensity on T1-weighted images and a hypointensity on T2-weighted images
  • Powder burn hemorrhages
Teratoma
  • 10-30 y/o
+/– +/–
  • We may see evidence of fat components
Dysgerminoma
  • in the second to third decade of life
+ +/– +/–
  • We may see ovarian mass with septation which are hyperintense on T1 and hypo or isointense on T2 imaging
  • Sheets fried egg appearance cells
Yolk sac tumor + +
  • High levels of AFP
  • In US we may see a combination of echogenic and hypoechoic components
  • Yellow appearance
  • Schiller-Duval bodies (glomeruli like structures)
Fibroma
  • >50 y/o
  • Pulling sensation in the groin
+/–
  • In CT scan we may see a unilateral mass with poor contrast enhancement
  • Low signal intensity on T1 and T2
Thecoma
  • >50 y/o
+/–
Granulosa cell tumor
  • 50-60 y/o
+ +/–
Sertoli-leydig cell tumor
  • 15 to 35 y/o
+/–
  • In US we may see unilateral Well-defined hypoechoic lesion
  • Low T2 signal intensity
  • areas of high signal intensity
Brenner tumor
  • >55 y/o
+/–
  • Hypointense on T2 because of fibrous content
  • Most of the times it's an accidental finding
Krukenberg tumor
  • >55 y/o
+/– +/–

Based on underlying malignancy

Tubal tubo-ovarian abscess + + + +
  • hypointense in T1 and heterogeneous in T2
Ectopic pregnancy + + +/– +
  • NA
  • NA
Hydrosalpinx
  • NA
+ +/–
  • NA
Salpingitis + + + +
  • In US we may see , edematous and thickened endosalpingeal folds
  • NA
  • NA
Fallopian tube carcinoma
  • >60 y/o
+ + + +/–
  • Low signal on T1
  • In case of hemorrhage inside the tumor we may see high signal intensity on T1
  • Low or of intermediate signal on T2
  • Based on the tumor type we may have different biopsy finding
Uterine Leiomyoma + + +/–
  • Low to intermediate signal intensity on T1 and T2
  • In case of necrosis inside the mass, there might be some high signal lesions on T2
Choriocarcinoma + + +/– +
  • We may see an infiltrative uterine mass and thickening of uterine wall
Leiomyosarcoma
  • >55 y/o
+ + +/–
  • Increased uterine size
  • Irregular central zones of low signal intensity (tumor necrosis)
Pregnancy +/− +/− +/−
  • NA
Non-gynecologic
GIT Appendiceal abscess
  • NA
+ + +/– +
  • NA
Appendiceal neoplasm[1] + + +/–
  • Soft tissue mass in the appendix
  • We may see invasion to other structures
  • Gray/yellowi color
  • Cystic structures with angiolymphatic invasion
Diverticular abscess
  • >50 y/o
+ + +/– +
  • Ill-defined lesion with air and fluid inside
  • Adjacent bowel loop wall thickening
  • Smudged mesenteric fat
  • We may see a lesion with air and fluid inside
  • NA
Colorectal cancer
  • >50 y/o
+ + +/–
  • We may see tumor mass and the extension of tumor to other structures
Renal

Bladder

Pelvic kidney[2]
  • NA
−/+

In case of sever hydronephrosis or renal stone we may have pelvic pain

  • We may see normal kidney structure
  • NA
  • It may cause tract infection (UTI), obstruction, and renal calculi.
  • It may be associated with RCC
Bladder cancer[3][4][5]
  • ≥65 y/o
+
  • isointense compared to muscle in T1
  • slightly hyperintense compared to muscle in T2
Others Retroperitoneal sarcoma[6][7][8][9]
  • 40-50 y/o
+ +

check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)

check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase

  • Bladder tumour–associated antigen (BTA)
  • Nuclear matrix proteins (NMP)
  • Mucin and carcinoembryonic antigen (CEA)

References

  1. Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019
  2. Weizer, Alon Z.; Springhart, W. Patrick; Ekeruo, Wesley O.; Matlaga, Brian R.; Tan, Yeh H.; Assimos, Dean G.; Preminger, Glenn M. (2005). "Ureteroscopic management of renal calculi in anomalous kidneys". Urology. 65 (2): 265–269. doi:10.1016/j.urology.2004.09.055. ISSN 0090-4295.
  3. Barentsz JO, Jager GJ, Witjes JA, Ruijs JH (1996). "Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT". Eur Radiol. 6 (2): 129–33. PMID 8797968.
  4. Shariat SF, Karam JA, Lotan Y, Karakiewizc PI (2008). "Critical evaluation of urinary markers for bladder cancer detection and monitoring". Rev Urol. 10 (2): 120–35. PMC 2483317. PMID 18660854.
  5. Metts MC, Metts JC, Milito SJ, Thomas CR (June 2000). "Bladder cancer: a review of diagnosis and management". J Natl Med Assoc. 92 (6): 285–94. PMC 2640522. PMID 10918764.
  6. Storm FK, Mahvi DM (July 1991). "Diagnosis and management of retroperitoneal soft-tissue sarcoma". Ann. Surg. 214 (1): 2–10. PMC 1358407. PMID 2064467.
  7. Francis IR, Cohan RH, Varma DG, Sondak VK (August 2005). "Retroperitoneal sarcomas". Cancer Imaging. 5: 89–94. doi:10.1102/1470-7330.2005.0019. PMID 16154826.
  8. Silverstein, Murray N.; Wakim, Khalil G.; Bahn, Robert C. (1964). "Hypoglycemia associated with neoplasia". The American Journal of Medicine. 36 (3): 415–423. doi:10.1016/0002-9343(64)90168-8. ISSN 0002-9343.
  9. Storm FK, Mahvi DM (July 1991). "Diagnosis and management of retroperitoneal soft-tissue sarcoma". Ann. Surg. 214 (1): 2–10. PMC 1358407. PMID 2064467.

Template:WH Template:WS